These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2428606)

  • 1. Properties of progestin-binding protein in benign hypertrophic human prostate.
    Akimoto S; Sato R; Kodama T; Zama S; Fuse H; Shimazaki J
    Endocrinol Jpn; 1986 Jun; 33(3):423-32. PubMed ID: 2428606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of dihydrotestosterone, R 1881 and R 5020 in cytosols from normal, benign hypertrophic and cancerous human prostates.
    Nozumi K; Sato R; Ito H; Maruoka M; Shimazaki J
    Urol Int; 1981; 36(2):79-87. PubMed ID: 6169181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of androgen receptor in cytosols from normal, benign hypertrophic and cancerous human prostates.
    Shimazaki J; Hikage T; Sato R; Kodama T; Ito H
    Endocrinol Jpn; 1981 Dec; 28(6):725-34. PubMed ID: 6179768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of estrogen-induced progestin binding in cytosol of the R3327 prostatic carcinoma of the rat.
    Mobbs BG; Johnson IE
    J Steroid Biochem; 1985 Jan; 22(1):57-62. PubMed ID: 3871881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 16 beta-ethyl-17 beta-hydroxy-4-estren-3-one (TSAA-291) on the binding of promegestone (R5020) and methyltrienolone (R1881) to hyperplastic and neoplastic human prostate.
    Bashirelahi N; Ganesan S; Ekiko DB; Young JD; Shida K; Yamanaka H; Takahashi E
    J Steroid Biochem; 1986 Sep; 25(3):367-74. PubMed ID: 2430141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for an androgen-binding component in the cytosol of the human term placenta.
    Stanley RL; Milwidsky A; Besch PK; Milwidsy A
    Am J Obstet Gynecol; 1980 Apr; 136(8):1003-5. PubMed ID: 6966131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progestin binding in benign hyperplastic prostatic tissue.
    Sirett DA
    J Steroid Biochem; 1983 Jul; 19(1A):163-7. PubMed ID: 6193339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of androgen receptors in human benign prostatic hypertrophy with two synthetic radiolabeled ligands.
    Schwemmer B; Böttger I; Schiessl J; Reidel G; Schütz W
    Urol Int; 1986; 41(2):133-8. PubMed ID: 2425471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of mibolerone to androgen receptor of benign hypertrophic human prostate. Comparison with R1881.
    Akimoto S; Fuse H; Sato R; Zama S; Shimazaki J
    Endocrinol Jpn; 1985 Feb; 32(1):141-52. PubMed ID: 2410244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progestin-binding protein in human benign prostatic hypertrophy.
    Kodama T; Ito M; Sato R; Ito H; Shimazaki J
    Endocrinol Jpn; 1981 Apr; 28(2):175-85. PubMed ID: 6171422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low molecular weight component of androgen receptor in cytosols from benign hypertrophic human prostate treated with high KCl solution.
    Kodama T; Fuse H; Shimazaki J
    Endocrinol Jpn; 1982 Jun; 29(3):325-33. PubMed ID: 6184218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding to R 1881 (methyltrienolone) of proteins from human benign prostatic hypertrophy.
    Kodama T; Hasebe C; Shimazaki J
    Endocrinol Jpn; 1980 Apr; 27(2):229-37. PubMed ID: 6157523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of [3H] methyltrienolone (R 1881) in rat prostate and human benign prostatic hypertrophy (BPH).
    Asselin J; Labrie F; Gourdeau Y; Bonne C; Raynaud JP
    Steroids; 1976 Oct; 28(4):449-59. PubMed ID: 64005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc concentration and progestin receptor in human benign hyperplastic prostate.
    Imai K; Schneider SL; Drury RE; Murphy GP; Sandberg AA
    J Urol; 1984 Aug; 132(2):367-71. PubMed ID: 6204067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interaction of pregna-D'-pentaranes--pentacyclic derivatives of progesterone--with gestagen-binding sites of uterine cytosol].
    Fanchenko ND; Kamernitskiĭ AV; Minina LS; Levina IS; Alekseeva ML
    Biull Eksp Biol Med; 1988 Jun; 105(6):679-81. PubMed ID: 3390587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of 7-8S progestin binding protein in human prostate using vertical tube rotor.
    Schneider SL; Pontes JE; Greco JM; Murphy GP; Sandberg AA
    J Steroid Biochem; 1984 Mar; 20(3):715-23. PubMed ID: 6538623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone binding protein in the bovine corpus luteum.
    Willcox DL; Thorburn GD
    J Steroid Biochem; 1981 Sep; 14(9):841-50. PubMed ID: 6170841
    [No Abstract]   [Full Text] [Related]  

  • 18. Steroid receptor content in cytosol from normal and hyperplastic human prostates.
    Ekman P; Snochowski M; Dahlberg E; Bression D; Högberg B; Gustafsson JA
    J Clin Endocrinol Metab; 1979 Aug; 49(2):205-15. PubMed ID: 88456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of R5020 and RU486 binding to progesterone receptor from calf uterus.
    Hurd C; Moudgil VK
    Biochemistry; 1988 May; 27(10):3618-23. PubMed ID: 3408715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the cytosol androgen receptor of the human prostate.
    Wilbert DM; Griffin JE; Wilson JD
    J Clin Endocrinol Metab; 1983 Jan; 56(1):113-20. PubMed ID: 6183286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.